References
- Bonnet F, Morlat P, Chêne G, Mercié P, Neau D, Chossat I, et al. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. HIV Med. 2002;3(3):195-9. PubMed | Google Scholar
- Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 1999. 2006 Sep;43(1):27-34. PubMed | Google Scholar
- Etard J-F, Ndiaye I, Thierry-Mieg M, Guèye NFN, Guèye PM, Lanièce I, et al. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS Lond Engl. 2006 May 12;20(8):1181-9. PubMed | Google Scholar
- Monforte A d'Arminio, Lepri AC, Rezza G, Pezzotti P, Antinori A, Phillips AN, et al. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I CO N A, Study Group; AIDS. 2000 Mar;14(5):499-507. PubMed | Google Scholar
- Cesar C, Shepherd BE, Krolewiecki AJ, Fink VI, Schechter M, Tuboi SH, et al. Rates and Reasons for Early Change of First HAART in HIV-1-Infected Patients in 7 Sites throughout the Caribbean and Latin America, Myer L, editor. PLoS ONE. 2010 Jun 1;5(6):e10490. PubMed | Google Scholar
- Mocroft A, Youle M, Moore A, Sabin CA, Madge S, Lepri AC, et al. Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. AIDS. 2001 Jan;15(2):185-94. PubMed | Google Scholar
- Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, et al. Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. J Acquir Immune Defic Syndr 1999. 2006 Jan 1;41(1):53-8. PubMed | Google Scholar
- Tayal V, Gupta U, Nagpal M, Kumar S. Adverse drug reactions to antiretroviral therapy in aids patients at a tertiary care hospital in India: A prospective observational study. Indian J Med Sci. 2010;64(6):245. PubMed | Google Scholar
- Namme Luma H, Doualla M-S, Choukem S-P, Temfack
E, et al. Adverse drug reactions
of Highly Active Antiretroviral Therapy (HAART) in
HIV infected patients at the
General Hospital, Douala, Cameroon: a cross sectional
study. Pan Afr Med J. 2012;12:87. PubMed | Google
Scholar
- Curkendall SM, Richardson JT, Emons MF, Fisher AE, Everhard F. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy. HIV Med. 2007 Nov;8(8):483-90. PubMed | Google Scholar
- WHO. The 3 by 5 Initiative. WHO.
Available from: http://www.who.int/3by5/en/. Accessed
on 29/08/2013.
- WHO. Scaling up antiretroviral therapy in resource-limited
settings: Treatment guidelines for a public health
approach.
Available
from: http://www.who.int/3by5/publications/documents/arv_guidelines/en/.
Accessed on 29/08/2013.
- Teodor A, Teodor D, Luca V. Side effects of antiretroviral
therapy. Rev Med Chir Soc Med Nat Iasi. 2004 Mar;108(1):23-6. PubMed | Google
Scholar
- Subbaraman R, Chaguturu SK, Mayer KH, Flanigan TP, Kumarasamy N. Adverse Effects of Highly Active Antiretroviral Therapy in Developing Countries. Clin Infect Dis. 2007 Oct 15;45(8):1093-101. PubMed | Google Scholar
- Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleenal B, Lai AR, Saghayam S, et al. Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients. AIDS Patient Care STDs. 2008 Apr;22(4):337-44. PubMed | Google Scholar
- Wabe N, Woldemedhin B. The reason for regimen change among HIV/AIDS patients initiated on first line highly active antiretroviral therapy in Southern Ethiopia. North Am J Med Sci. 2012;4(1):19. PubMed | Google Scholar
- Geretti AM, Patel M, Sarfo FS, Chadwick D, Verheyen J, Fraune M, et al. Detection of Highly Prevalent Hepatitis B Virus Coinfection among HIV-Seropositive Persons in Ghana. J Clin Microbiol. 2010 Sep 1;48(9):3223-30. PubMed | Google Scholar
- Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleenol B, Saghayam S, Yepthomi T, et al. Gender-based differences in treatment and outcome among HIV patients in South India. J Womens Heal 2002. 2008 Nov;17(9):1471-5. PubMed | Google Scholar
- Currier JS, Spino C, Grimes J, Wofsy CB, Katzenstein DA, Hughes MD, et al. Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. J Acquir Immune Defic Syndr. 2000;24(4):316-24. PubMed | Google Scholar